These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24854104)

  • 1. The novel HDAC inhibitor OBP-801/YM753 enhances the effects of 5-fluorouracil with radiation on esophageal squamous carcinoma cells.
    Furutani A; Sowa Y; Fujiwara H; Otsuji E; Sakai T
    Oncol Res; 2014; 21(5):281-6. PubMed ID: 24854104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERRATUM.
    Furutani A; Sowa Y; Fujiwara H; Otsuji E; Sakai T
    Oncol Res; 2016 Jan; 23(1):87. PubMed ID: 29021025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a novel HDAC inhibitor OBP-801/YM753 and a PI3K inhibitor LY294002 synergistically induces apoptosis in human endometrial carcinoma cells due to increase of Bim with accumulation of ROS.
    Yoshioka T; Yogosawa S; Yamada T; Kitawaki J; Sakai T
    Gynecol Oncol; 2013 May; 129(2):425-32. PubMed ID: 23403163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma.
    Mynhardt C; Damelin LH; Jivan R; Peres J; Prince S; Veale RB; Mavri-Damelin D
    J Cell Biochem; 2018 Jan; 119(1):1193-1203. PubMed ID: 28722177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models.
    Hou W; Qin X; Zhu X; Fei M; Liu P; Liu L; Moon H; Zhang P; Greshock J; Bachman KE; Ye BC; Wang H; Zang CY
    Oncol Rep; 2013 Aug; 30(2):707-14. PubMed ID: 23708506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.
    Liu Y; Wang X; Wang Y; Zhang Y; Zheng K; Yan H; Zhang L; Chen W; Wang X; Liu Q; Wang S; Wang Y
    Int J Oncol; 2015 Jan; 46(1):299-307. PubMed ID: 25333998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Yusup G; Akutsu Y; Mutallip M; Qin W; Hu X; Komatsu-Akimoto A; Hoshino I; Hanari N; Mori M; Akanuma N; Isozaki Y; Matsubara H
    Int J Oncol; 2014 Apr; 44(4):1146-52. PubMed ID: 24535229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G₂ Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells.
    Akiyama M; Sowa Y; Taniguchi T; Watanabe M; Yogosawa S; Kitawaki J; Sakai T
    Oncol Res; 2017 Sep; 25(8):1245-1252. PubMed ID: 28117030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.
    Lee JH; Park JH; Jung Y; Kim JH; Jong HS; Kim TY; Bang YJ
    Mol Cancer Ther; 2006 Dec; 5(12):3085-95. PubMed ID: 17172411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation.
    Sprio AE; Di Scipio F; Ceppi P; Salamone P; Di Carlo F; Scagliotti GV; Papotti M; Ceccarelli A; Berta GN
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):983-9. PubMed ID: 22139443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between radiation dose and pathological complete response after preoperative radiochemotherapy in esophageal squamous cell cancer.
    Ordu AD; Nieder C; Geinitz H; Scherer V; Kup PG; Schuster T; Combs SE; Fakhrian K
    Anticancer Res; 2014 Dec; 34(12):7255-61. PubMed ID: 25503157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of carbon-ion radiotherapy combined with a novel histone deacetylase inhibitor, cyclic hydroxamic-acid-containing peptide 31 in human esophageal squamous cell carcinoma.
    Kano M; Yamada S; Hoshino I; Murakami K; Akutsu Y; Sakata H; Nishimori T; Usui A; Miyazawa Y; Kamada T; Tsujii H; Matsubara H
    Anticancer Res; 2009 Nov; 29(11):4433-8. PubMed ID: 20032389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
    Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
    Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative inhibitory effect of sinomenine combined with 5-fluorouracil on esophageal carcinoma.
    Wang J; Yang ZR; Dong WG; Zhang JX; Guo XF; Song J; Qiu S
    World J Gastroenterol; 2013 Dec; 19(45):8292-300. PubMed ID: 24363520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel HDAC inhibitor OBP-801 and a PI3K inhibitor LY294002 synergistically induce apoptosis via the suppression of survivin and XIAP in renal cell carcinoma.
    Yamada T; Horinaka M; Shinnoh M; Yoshioka T; Miki T; Sakai T
    Int J Oncol; 2013 Oct; 43(4):1080-6. PubMed ID: 23900601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorouracil up-regulates interferon pathway gene expression in esophageal cancer cells.
    Matsumura Y; Yashiro M; Ohira M; Tabuchi H; Hirakawa K
    Anticancer Res; 2005; 25(5):3271-8. PubMed ID: 16101138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
    Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model.
    Shindoh N; Mori M; Terada Y; Oda K; Amino N; Kita A; Taniguchi M; Sohda KY; Nagai K; Sowa Y; Masuoka Y; Orita M; Sasamata M; Matsushime H; Furuichi K; Sakai T
    Int J Oncol; 2008 Mar; 32(3):545-55. PubMed ID: 18292931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
    Okada K; Hakata S; Terashima J; Gamou T; Habano W; Ozawa S
    Oncol Rep; 2016 Oct; 36(4):1875-85. PubMed ID: 27509880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.